Payment overview · 2025
General Payments
$130.94
1 reported records · 1 companies
Healthcare provider profile · identity verified
Benjamin O Osowa, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · ROSEVILLE, MI · NPI 1053305110
Verified facts
What the public records show
CMS Open Payments records show Benjamin O Osowa, M.D. received $130.94 in general payments during 2025 across 1 reported records.
Amgen Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Amgen Inc. | Unresolved — no canonical attribution shown | $130.94 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $130.94 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| EVENITY Normalized: evenity |
Biological | Amgen Inc. | $130.94 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Rosuvastatin Calcium | Rosuvastatin Calcium | 683 | 201 |
| Levothyroxine Sodium | Levothyroxine Sodium | 518 | 139 |
| Amlodipine Besylate | Amlodipine Besylate | 463 | 133 |
| Atorvastatin Calcium | Atorvastatin Calcium | 453 | 136 |
| Metoprolol Succinate | Metoprolol Succinate | 366 | 108 |
| Losartan Potassium | Losartan Potassium | 361 | 107 |
| Lisinopril | Lisinopril | 286 | 78 |
| Omeprazole | Omeprazole | 267 | 77 |
| Alprazolam | Alprazolam | 258 | 54 |
| Pantoprazole Sodium | Pantoprazole Sodium | 232 | 74 |
| Carvedilol | Carvedilol | 222 | 58 |
| Metformin Hcl | Metformin Hcl | 216 | 60 |
| Trazodone Hcl | Trazodone Hcl | 215 | 59 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 205 | 42 |
| Gabapentin | Gabapentin | 175 | 52 |
| Eliquis | Apixaban | 172 | 39 |
| Famotidine | Famotidine | 172 | 52 |
| Potassium Chloride | Potassium Chloride | 166 | 45 |
| Tamsulosin Hcl | Tamsulosin Hcl | 162 | 48 |
| Hydrochlorothiazide | Hydrochlorothiazide | 158 | 47 |
| Jardiance | Empagliflozin | 155 | 39 |
| Allopurinol | Allopurinol | 153 | 40 |
| Ezetimibe | Ezetimibe | 150 | 40 |
| Meloxicam | Meloxicam | 150 | 46 |
| Clopidogrel | Clopidogrel Bisulfate | 148 | 42 |
| Simvastatin | Simvastatin | 140 | 39 |
| Ozempic | Semaglutide | 124 | 32 |
| Furosemide | Furosemide | 117 | 41 |
| Metoprolol Tartrate | Metoprolol Tartrate | 117 | 29 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 114 | 33 |
| Pioglitazone Hcl | Pioglitazone Hcl | 114 | 39 |
| Metformin Hcl Er | Metformin Hcl | 113 | 35 |
| Duloxetine Hcl | Duloxetine Hcl | 111 | 32 |
| Fluticasone Propionate | Fluticasone Propionate | 108 | 40 |
| Glimepiride | Glimepiride | 105 | 29 |
| Lovastatin | Lovastatin | 104 | 29 |
| Mounjaro | Tirzepatide | 90 | 17 |
| Bupropion Xl | Bupropion Hcl | 84 | 25 |
| Montelukast Sodium | Montelukast Sodium | 84 | 30 |
| Chlorthalidone | Chlorthalidone | 82 | 20 |
| Prednisone | Prednisone | 82 | 70 |
| Ibuprofen | Ibuprofen | 79 | 23 |
| Tramadol Hcl | Tramadol Hcl | 79 | 21 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 79 | 19 |
| Escitalopram Oxalate | Escitalopram Oxalate | 78 | 33 |
| Methocarbamol | Methocarbamol | 76 | 32 |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 69 | 21 |
| Pravastatin Sodium | Pravastatin Sodium | 69 | 23 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 68 | 18 |
| Spironolactone-Hctz | Spironolact/Hydrochlorothiazid | 67 | 21 |
| Finasteride | Finasteride | 65 | 19 |
| Januvia | Sitagliptin Phosphate | 65 | 18 |
| Buspirone Hcl | Buspirone Hcl | 63 | 12 |
| Celecoxib | Celecoxib | 62 | 15 |
| Spironolactone | Spironolactone | 60 | 21 |
| Calcitriol | Calcitriol | 59 | 18 |
| Tizanidine Hcl | Tizanidine Hcl | 59 | 19 |
| Atenolol | Atenolol | 58 | 14 |
| Donepezil Hcl | Donepezil Hcl | 58 | 20 |
| Mirtazapine | Mirtazapine | 56 | 13 |
| Zolpidem Tartrate | Zolpidem Tartrate | 56 | 11 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 55 | 14 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 55 | 19 |
| Amitriptyline Hcl | Amitriptyline Hcl | 54 | 14 |
| Methylprednisolone | Methylprednisolone | 53 | 48 |
| Pregabalin | Pregabalin | 52 | 19 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 51 | 17 |
| Testosterone Cypionate | Testosterone Cypionate | 51 | suppressed |
| Sertraline Hcl | Sertraline Hcl | 49 | 15 |
| Raloxifene Hcl | Raloxifene Hcl | 48 | 12 |
| Nifedipine Er | Nifedipine | 47 | 17 |
| Alendronate Sodium | Alendronate Sodium | 46 | 19 |
| Cephalexin | Cephalexin | 45 | 42 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 45 | 15 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 44 | 15 |
| Memantine Hcl | Memantine Hcl | 44 | 15 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 43 | suppressed |
| Torsemide | Torsemide | 43 | 14 |
| Xarelto | Rivaroxaban | 43 | 11 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 41 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 41 | 11 |
| Hydralazine Hcl | Hydralazine Hcl | 40 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 40 | 23 |
| Mupirocin | Mupirocin | 39 | 17 |
| Lorazepam | Lorazepam | 38 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 38 | 15 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 38 | 11 |
| Doxycycline Hyclate | Doxycycline Hyclate | 37 | 36 |
| Enalapril Maleate | Enalapril Maleate | 37 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 37 | 11 |
| Citalopram Hbr | Citalopram Hydrobromide | 35 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 35 | 19 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 34 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 33 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 33 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 33 | suppressed |
| Baclofen | Baclofen | 32 | 13 |
| Topiramate | Topiramate | 32 | 12 |
| Liothyronine Sodium | Liothyronine Sodium | 31 | suppressed |
| Clonazepam | Clonazepam | 30 | suppressed |
| Levetiracetam | Levetiracetam | 30 | suppressed |
| Lidocaine | Lidocaine | 30 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 29 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 29 | suppressed |
| Estradiol | Estradiol | 28 | 15 |
| Fluconazole | Fluconazole | 28 | 16 |
| Propranolol Hcl Er | Propranolol Hcl | 28 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 28 | suppressed |
| Ondansetron Odt | Ondansetron | 27 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 27 | suppressed |
| Cefuroxime | Cefuroxime Axetil | 26 | 21 |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 26 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 26 | 21 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 26 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 25 | suppressed |
| Repatha Sureclick | Evolocumab | 25 | suppressed |
| Synthroid | Levothyroxine Sodium | 25 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 25 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 25 | 11 |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 25 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 24 | suppressed |
| Eszopiclone | Eszopiclone | 24 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 24 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 24 | suppressed |
| Colchicine | Colchicine | 23 | 12 |
| Divalproex Sodium | Divalproex Sodium | 23 | suppressed |
| Klor-Con M20 | Potassium Chloride | 23 | suppressed |
| Nitroglycerin | Nitroglycerin | 23 | suppressed |
| Repaglinide | Repaglinide | 23 | 11 |
| Azelastine Hcl | Azelastine Hcl | 22 | 14 |
| Fenofibrate | Fenofibrate | 22 | suppressed |
| Myrbetriq | Mirabegron | 22 | 11 |
| Symbicort | Budesonide/Formoterol Fumarate | 22 | suppressed |
| Valsartan | Valsartan | 22 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 21 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 21 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 20 | suppressed |
| Nystatin | Nystatin | 19 | suppressed |
| Primidone | Primidone | 19 | suppressed |
| Temazepam | Temazepam | 19 | suppressed |
| Azithromycin | Azithromycin | 18 | 16 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 18 | 17 |
| Entresto | Sacubitril/Valsartan | 18 | suppressed |
| Folic Acid | Folic Acid | 18 | suppressed |
| Hydrocortisone | Hydrocortisone | 18 | 12 |
| Dicyclomine Hcl | Dicyclomine Hcl | 17 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 17 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 17 | suppressed |
| Bumetanide | Bumetanide | 16 | suppressed |
| Methylphenidate Hcl | Methylphenidate Hcl | 16 | suppressed |
| Mirabegron Er | Mirabegron | 16 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 16 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 15 | suppressed |
| Lansoprazole | Lansoprazole | 15 | suppressed |
| Stiolto Respimat | Tiotropium Br/Olodaterol Hcl | 15 | suppressed |
| Ultra-Fine Nano Pen Needle | Pen Needle, Diabetic | 15 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 14 | 14 |
| Farxiga | Dapagliflozin Propanediol | 14 | suppressed |
| Ibu | Ibuprofen | 14 | suppressed |
| Toujeo Max Solostar | Insulin Glargine,hum.Rec.Anlog | 14 | suppressed |
| Tradjenta | Linagliptin | 14 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 14 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 13 | suppressed |
| Atropine Sulfate | Atropine Sulfate | 13 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 13 | suppressed |
| Sotalol | Sotalol Hcl | 13 | suppressed |
| Tadalafil | Tadalafil | 13 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 12 | suppressed |
| Cabergoline | Cabergoline | 12 | suppressed |
| Cinacalcet Hcl | Cinacalcet Hcl | 12 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 12 | suppressed |
| Dabigatran Etexilate | Dabigatran Etexilate Mesylate | 12 | suppressed |
| Diazepam | Diazepam | 12 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 12 | suppressed |
| Droplet Pen Needle | Pen Needle, Diabetic | 12 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 12 | suppressed |
| Ketoconazole | Ketoconazole | 12 | suppressed |
| Latanoprost | Latanoprost | 12 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 12 | suppressed |
| Silodosin | Silodosin | 12 | suppressed |
| Trulicity | Dulaglutide | 12 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 12 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 11 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 11 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 11 | suppressed |
| Naltrexone Hcl | Naltrexone Hcl | 11 | suppressed |
| Varenicline Tartrate | Varenicline Tartrate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $130.94 · 1 records | Amgen Inc. | EVENITY | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error